Drugs Flashcards
GHB
Gamma-hydroxy-butyrate
Omeprazole
PPI
MoA: irreversible blockade of H+/K+ ATPase on gastric parietal cell
cytochrome P450 inhibitor = raised INR = bleeding risk
SEs: hyponatraemia (via SIADH), hypomagnesaemia, increased risk of osteoporosis and fractures (due to calcium & magnesium malabsorption), increased risk of C. difficile infection, microscopic colitis
Lansoprazole
PPI
MoA: irreversible blockade of H+/K+ ATPase on gastric parietal cell
SEs: hyponatraemia, hypomagnesaemia, increased risk of osteoporosis and fractures (due to calcium & magnesium malabsorption), increased risk of C. difficile infection, microscopic colitis
Ramipril
ACEi
Check serum creatinine and potassium levels pre-treatment, after 7 days and 1 month, and whenever dose increased to exclude renal artery stenosis and monitor potassium levels
SEs: dry cough (due to effects on bradykinin), angioedema (hypersensitivity reaction hence stop ACEi), hyperkalaemia, 1st dose hypotension (seen if pt taking diuretic)
Contraindicated in pregnancy/breastfeeding (risk of renal failure, foetal abnormalities e.g. cranial/cardiac defects, or oligohydramnios), renovascular disease, aortic stenosis (may cause hypotension)
Stopped prior to surgery
Lisinopril
ACEi
Check serum Creatinine and potassium levels pre-treatment, after 7 days and 1 month, and whenever dose increased to exclude renal artery stenosis and monitor potassium levels
SEs: dry cough (due to effects on bradykinin), angioedema (hypersensitivity reaction hence stop ACEi), hyperkalaemia, 1st dose hypotension (seen if pt taking diuretic)
Contraindicated in pregnancy/breastfeeding (risk of renal failure, foetal abnormalities e.g. cranial/cardiac defects, or oligohydramnios), renovascular disease, aortic stenosis (may cause hypotension)
Stopped prior to surgery
Enalapril
ACEi
Check serum Creatinine and potassium levels pre-treatment, after 7 days and 1 month, and whenever dose increased to exclude renal artery stenosis and monitor potassium levels
SEs: dry cough (due to effects on bradykinin), angioedema (hypersensitivity reaction hence stop ACEi), hyperkalaemia, 1st dose hypotension (seen if pt taking diuretic)
Contraindicated in pregnancy/breastfeeding (risk of renal failure, foetal abnormalities e.g. cranial/cardiac defects, or oligohydramnios), renovascular disease, aortic stenosis (may cause hypotension)
Stopped prior to surgery
Candesartan
Angiotensin-II receptor blockers
Blocks AT1 receptor (subtype of the angiotensin II receptor)
Check serum Creatinine and potassium levels pre-treatment, after 7 days and 1 month, and whenever dose increased to exclude renal artery stenosis and monitor potassium levels
Irbesartan
Angiotensin-II receptor blockers
Blocks AT1 receptor (subtype of the angiotensin II receptor)
Check serum Creatinine and potassium levels pre-treatment, after 7 days and 1 month, and whenever dose increased to exclude renal artery stenosis and monitor potassium levels
Losartan
Angiotensin-II receptor blockers
Blocks AT1 receptor (subtype of the angiotensin II receptor)
Check serum creatinine and potassium levels pre-treatment, after 7 days and 1 month, and whenever dose increased to exclude renal artery stenosis and monitor potassium levels
SEs: diarrhoea, abdominal pain, dizziness
Amlodipine
Dihydropyridine calcium channel blocker
Reduce calcium ion flow to vascular smooth muscle cells to vasodilate, reducing BP, and reducing the force and rate of the heart beat to prevent angina
SEs: ankle oedema, headache, constipation, diarrhoea, flushing
Verapamil
Non-dihydropyridine calcium channel blocker
Reduce calcium ion flow to vascular smooth muscle cells to vasodilate, reducing BP, and reducing the force and rate of the heart beat to prevent angina
Used for cluster headache prophylaxis (poss. due to vasodilatory effect on cerebral arteries)
SEs: Heart failure, constipation, hypotension, bradycardia, flushing
Avoid if pt is on a beta blocker (risk of complete heart block), or if pt is known to have heart failure
Diltiazem
Calcium channel blocker
Reduce calcium ion flow to vascular smooth muscle cells to vasodilate, reducing BP, and reducing the force and rate of the heart beat to prevent angina
SEs: Hypotension, bradycardia, heart failure, ankle swelling
Nifedipine
Dihydropyridine calcium channel blocker
Reduce calcium ion flow to vascular smooth muscle cells to vasodilate, reducing BP, and reducing the force and rate of the heart beat to prevent angina
SEs: flushing, headache, ankle swelling
Bumetanide
Loop diuretics Inhibits resorption in LoH Mainly used for HTN with CKD Hypokalaemia may lead to hypotension Cause or exacerbate gout
Furosemide
Loop diuretics Inhibits resorption in LoH Mainly used for HTN with CKD Hypokalaemia may lead to hypotension Cause or exacerbate gout
Isosorbide mononitrate
Nitrates
Used to relieve angina
Tolerance may develop with standard release ISMN requiring a change in dose regime hence asymmetric dosing interval should be used
Glyceryl trinitrate
Nitrates
Used sublingually for angina attacks
Alfuzosin
Alpha adrenergic receptor antagonist
Causes vasodilation by inhibiting alpha-related vasoconstriction
Does not elevate glucose but increased insulin sensitivity may lower lipids
May cause postural hypotension in elderly
Doxazosin
Alpha adrenergic receptor antagonist
Causes vasodilation by inhibiting alpha-related vasoconstriction
Does not elevate glucose but increased insulin sensitivity may lower lipids
May cause postural hypotension in elderly
Tamsulosin
Alpha adrenergic receptor antagonist
Causes vasodilation by inhibiting alpha-related vasoconstriction
Does not elevate glucose but increased insulin sensitivity may lower lipids
May cause postural hypotension in elderly
Atenolol
Beta blockers
Used for stable angina tx (can be used in HF pt)
Avoid in HTN due to increased T2DM risk
Avoid in asthmatics
SEs: erectile dysfunction, bronchospasm, sleep disturbances, cold peripheries, fatigue
Beta-blockers can theoretically suppress all of the adrenergically mediated symptoms of hypoglycemia and thus can lead to unawareness of hypoglycemic events
May cause depressive symptoms
Bisoprolol
Beta blockers
Can be used as rate control in AF
Avoid in asthmatics and HF pts
SEs: erectile dysfunction, bronchospasm, sleep disturbances, cold peripheries, fatigue
Beta-blockers can theoretically suppress all of the adrenergically mediated symptoms of hypoglycemia and thus can lead to unawareness of hypoglycemic events
May cause depressive symptoms
Metoprolol
Beta blockers
Can be used as rate control in AF
Avoid in asthmatics and HF pts
SEs: erectile dysfunction, bronchospasm, sleep disturbances, cold peripheries, fatigue
Beta-blockers can theoretically suppress all of the adrenergically mediated symptoms of hypoglycemia and thus can lead to unawareness of hypoglycemic events
May cause depressive symptoms
Ipratropium bromide
Anti-muscarinic bronchodilators
Tiotropium
Anti-muscarinic bronchodilators
Betamethasone
Inhaled corticosteroid
Can be used topically for mild drug hypersensitivity reaction or drug eruption rash
SEs: risk of idiopathic intracranial HTN
Seretide
Fluticasone + Salmeterol
Salbutamol
Beta 2 agonist
Bronchodilator
Quetiapine
Atypical (2nd generation) antipsychotic
Olanzapine
Atypical (2nd generation) antipsychotic
Chlordiazepoxide
Benzodiazepine
Diazepam
Benzodiazepine
Used for anxiety disorders
Lorazepam
Benzodiazepine
Used for anxiety disorders
Midazolam
Benzodiazepine
Used for anxiety disorders
Temazepam
Benzodiazepine
Domperidone
D2 antagonist
Anti-emetic
Metoclopramide
D2 antagonist (central dopamine antagonist) Used for gastrointestinal causes of nausea/vomiting
Co-careldopa
Levodopa/carbidopa
Co-beneldopa
Levodopa
Diclofenac
NSAID
MoA: inhibit cyclooxygenase to reduce prostaglandin and thromboxane A2 production
SEs: urticaria, tinnitus
do not use with any form of cardiovascular disease e.g. IHD, PAD, cerebrovascular disease, HF
Ibuprofen
NSAID
MoA: inhibit cyclooxygenase to reduce prostaglandin and thromboxane A2 production
SEs: urticaria, tinnitus
Codeine
Weak/moderate opioid
SEs: urticaria
Dihydrocodeine
Weak/moderate opioid
SEs: urticaria
Fentanyl
Opioid
SEs: urticaria
Morphine
Opioid
SEs: urticaria
Oxycodone
Opioid
SEs: urticaria
Citalopram
SSRIs
Used for IBS if pt resistant to TCAs
cytochrome P450 inhibitor = raised INR = bleeding risk
IBS dose: 20-40mg PO OD
Fluoxetine
SSRIs
cytochrome P450 inhibitor = raised INR = bleeding risk
Amitriptyline
Tricyclic antidepressant
Used for IBS if laxatives, loperamide or antispasmodics have not helped
IBS dose: 10-25mg PO OD at bedtime
Dosulepin
Tricyclic antidepressant
Gelofusine
Colloid
Volplex
Colloid
Cephalexin/cefalexin
1st gen Cephalosporin
Cefuroxime
2nd gen Cephalosporin
Ceftriaxone
3rd gen Cephalosporin
1st line for gonorrhoea (IM)
Clarithromycin
Macrolides
Can interact with statins to cause statin-induced myopathy
Erythromycin
Macrolide antibiotic
Can interact with statins to cause statin-induced myopathy
Amphotericin
Anti-fungal
Fluconazole
Anti-fungal
Interacts with warfarin hence close INR monitoring required
Nystatin
Anti-fungal
Amoxicillin
Penicillin
SEs: urticaria
Co-amoxiclav
Penicillin
Used for human and animal bites if the skin has been broken and blood is drawn
SEs: urticaria
Flucloxacillin
Penicillin
1st line tx for Erysipelas (500-1000mg QDS PO 5-7d) and most skin infections, 1st line for otitis externa
SEs: urticaria
Penicillin G
Penicillin
Benzylpenicillin - used IM as 1st line tx for syphilis
SEs: urticaria
Penicillin V
Penicillin
Phenoxymethylpenicillin
SEs: urticaria
Doxycycline
Tetracycline antibiotic V. cheap drug Avoid in pregnancy Can be used in malaria tx and prophylaxis Used as alternative drug for syphilis tx SEs: idiopathic intracranial HTN
Artesunate
Anti-protozoal
Chloroquine
Anti-protozoal
Anti-malarial drug
Quinine sulphate
Anti-protozoal
Used for treatment of malaria
Dexamethasone
Corticosteroids
Mild anti-emetic effects hence may be given preoperatively to surgical patients
SEs: risk of idiopathic intracranial HTN
Hydrocortisone
Corticosteroids
SEs: risk of idiopathic intracranial HTN
Prednisolone
Topical corticosteroid
1st line treatment for ITP (high dose required)
SEs: risk of idiopathic intracranial HTN
Mesalazine
Aminosalicylates
SEs: steven-johnson syndrome
Loperamide hydrochloride
Anti-motility drug used for acute diarrhoea
Dose: 4mg initially, 2mg after each loose stool (max 16mg/day) for 5days
Ranitidine
Histamine (H2) receptor antagonists
Used if PPI poorly tolerated for dyspepsia
Macrogol
Osmotic laxatives
Lactulose
Osmotic laxative Used for constipation May be given to IBS sufferer Synthetic disaccharide with a sweet taste which can increase bloating in some patients 10-20 g (15-30 mL) PO OD
Senna
Stimulant laxative
Docusate sodium
Stimulant laxative
Spironolactone
Aldosterone antagonist
K+ sparing diuretic, used in Conn’s
Not licensed for HTN use but starting dose is 12.5mg (1/2 tablet)
SEs: hyperkalaemia, gynaecomastia
Perindopril
ACEi
Check serum Creatinine and potassium levels pre-treatment, after 7 days and 1 month, and whenever dose increased to exclude renal artery stenosis and monitor potassium levels
SEs: dry cough (due to effects on bradykinin), angioedema (hypersensitivity reaction hence stop ACEi), hyperkalaemia, 1st dose hypotension (seen if pt taking diuretic)
Contraindicated in pregnancy/breastfeeding (risk of renal failure, foetal abnormalities e.g. cranial/cardiac defects, or oligohydramnios), renovascular disease, aortic stenosis (may cause hypotension)
Stopped prior to surgery
Atropine sulfate
Antimuscarinic/anticholinergic
Used for IBS as an antispasmodic
GI spasm dose: 0.6-1.2mg OD at night
Also used for bradycardia
Hyoscine butylbromide
Antimuscarinic/anticholinergic
Used for IBS as an antispasmodic to relieve symptomatic GI smooth muscle spasm
Dose: 10mg PO TDS (up to 20mg QDS)
Clopidogrel
Antiplatelet, P2Y12 receptor antagonist
75mg given lifelong post-TIA/Stroke (after initial 2 weeks of aspirin)
Used to reduce cardiovascular risk e.g. in peripheral arterial disease (along with a statin)
Lercanidipine
Dihydropyridine calcium channel blocker
Reduce calcium ion flow to vascular smooth muscle cells to vasodilate, reducing BP, and reducing the force and rate of the heart beat to prevent angina
SEs: ankle oedema and headache
Digoxin
Cardiac glycoside
Use: rate control in atrial fibrillation, symptom improvement in HF (due to positive inotropic effect)
MoA: reduces conduction through AVN, increases force of contraction (by inhibiting Na+/K+ ATPase pump in cardiac muscle and vagus stimulation)
Narrow therapeutic index but regular monitoring not required, except in suspected toxicity (8-12hrs after last dose)
SEs: toxicity causes xanthopsia(yellow/green-tinted vision), arrhythmias, low K+/Mg+
Tx of severe digoxin toxicity = digibind
Toxicity more likely with hypokalaemia
Direct Oral Anticoagulants (DOACs) Rivaroxaban
Reversible factor Xa inhibitors Dabigatran Edoxaban Apixaban Rivaroxaban Prevents conversion of prothrombin to thrombin and prolongs clotting time to prevent thrombus formation
Bendroflumethiazide
Thiazide-like diuretic
SEs: hypercalcaemia & hypocalciuria
Indapamide
Thiazide diuretic
Used for HTN treatment
SEs: hypercalcaemia & hypocalciuria
Alteplase
Fibrinolytics
Simvastatin
Statin
Used for angina
May cause statin-induced myopathy, higher risk if pt on macrolide
Not safe in pregnancy
Atorvastatin
Statin
Used for angina
1st line for secondary prevention of CVD = 80mg (high dose)
Not safe in pregnancy
Pravastatin
Statin
Used for angina
Not safe in pregnancy
Warfarin
Vitamin K antagonist Not safe in pregnancy Warfarin interacts with fluconazole Careful monitoring of INR is required Preferred anticoagulant for mitral stenosis
Salmeterol
Beta 2 agonist
Beclometasone
Inhaled corticosteroid
SEs: risk of idiopathic intracranial HTN
Fluticasone
Inhaled corticosteroid
SEs: risk of idiopathic intracranial HTN
Budesonide
Inhaled corticosteroid
SEs: risk of idiopathic intracranial HTN
Cyclizine
H1 receptor antagonist
Cetirizine
H1 receptor antagonist
Loratadine
H1 receptor antagonist
Antihistamine
Fexofenadine
H1 receptor antagonist
Chlorphenamine
H1 receptor antagonist
Symptomatic relief of allergy such as hay fever (allergic rhinitis), urticaria, food allergy, drug reactions
4mg every 4-6hrs PO (max. 24mg)
OR 10mg IV/IM for emergency relief (max. 4x)
Montelukast
Leukotriene receptor antagonist
Carbocysteine
Mucolytics
Donepezil
Acetylcholinesterase inhibitor
Venlafaxine
Selective serotonin-norepinephrine reuptake inhibitor
Used for major depression, panic disorder, generalised anxiety disorder, and social anxiety
Mirtazapine
Antidepressant
Citalopram
SSRI
cytochrome P450 inhibitor = raised INR = bleeding risk
Used for depressive disorders, panic disorders, social phobia, and OCD
Sertraline
SSRI
cytochrome P450 inhibitor = raised INR = bleeding risk
SEs: steven-johnson syndrome
Metoclopramide
D2 antagonist
Anti-emetic
Domperidone
D2 antagonist anti-emetic
Ondansetron
5HT3 antagonist that acts on the chemoreceptor trigger zone area of the medulla oblongata
May be given post-operatively to patients for anti-emetic effects
Used for chemotherapy-induced nausea/vomiting
SEs: constipation and prolonged QT interval
Haloperidol
1st generation anti-psychotic
Dopamine receptor antagonist
Used for raised ICP causes of nausea
Risperidone
Atypical (2nd generation) anti-psychotic
Tramadol
Weak/moderate opioids
SEs: urticaria
Sumatriptan
5HT1 receptor agonist
Used for acute management of cluster headaches and migraines with high flow oxygen